Table 2.
Characteristics | Hormone therapy | HER-2* status | ER** status | PR status† | Mean BMI‡ | |||||
---|---|---|---|---|---|---|---|---|---|---|
Yes | No | + | ־ | + | - | + | - | |||
Amenorrhea (n=70) | n (%) | 45 (77) | 25 (41) | 40 (65) | 30 (51) | 39 (68) | 31 (50) | 36 (66) | 34 (47) | 27.04 |
No amenorrhea (n=49) | 13 (22) | 36 (59) | 21 (34) | 28 (48) | 18 (31) | 31 (50) | 18 (33) | 31 (52) | 27.13 | |
P value | 0.0001 | 0.125 | 0.041 | 0.113 | 0.93 |
HER-2: Human Epidermal Growth Factor Receptor 2
ER: Estrogen Receptors
PR:Progestogen Receptor
BMI: Body Mass Index